seems like an overpriced purchase, when not taking into consideration the synergies.Not sure how much benefit a combined group can have on the imediate future, will be intersting to see the RQL 31 Dec 2010 results tommorow..
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025